VRTX - VERTEX PHARMACEUTICALS INC / MA
477.89
3.620 0.757%
Share volume: 989,412
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$474.27
3.62
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-02-2024 | 11-05-2024 | 02-13-2025 | 05-06-2025 | 08-05-2025 | 11-04-2025 | 02-13-2026 | |
| Assets | |||||||||
| Total Assets | 23.917 B | 20.132 B | 22.240 B | 22.533 B | 22.881 B | 24.037 B | 24.862 B | 25.643 B | |
| Current Assets | 13.289 B | 8.942 B | 9.804 B | 9.596 B | 10.009 B | 10.428 B | 10.570 B | 11.201 B | |
| Inventories | 813.100 M | 914.600 M | 1.080 B | 1.205 B | 1.360 B | 1.499 B | 1.627 B | 1.687 B | |
| Other Current Assets | 511.100 M | 575.400 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 511.100 M | 575.400 M | 1.285 B | 1.546 B | 1.527 B | 1.411 B | 1.347 B | 1.523 B | |
| Total Receivables | 1.793 B | 1.656 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 10.171 B | 5.796 B | 5.239 B | 4.570 B | 4.675 B | 4.972 B | 4.940 B | 5.085 B | |
| Total Non-current Assets | 10.629 B | 11.191 B | 4.704 B | 5.108 B | 5.157 B | 5.646 B | 5.723 B | 5.712 B | |
| Property Plant Equipment | 1.173 B | 1.201 B | 1.118 B | 1.228 B | 1.296 B | 1.335 B | 1.425 B | 1.520 B | |
| Other Assets | 801.400 M | 915.600 M | 11.318 B | 11.709 B | 11.576 B | 12.274 B | 12.868 B | 12.922 B | |
| Intangible Assets | 834.900 M | 837.500 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 1.088 B | 1.088 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 23.917 B | 20.132 B | 22.240 B | 22.533 B | 22.881 B | 24.037 B | 24.862 B | 25.643 B | |
| Total liabilities | 5.371 B | 5.357 B | 6.609 B | 6.124 B | 6.384 B | 6.861 B | 7.544 B | 6.977 B | |
| Total current liabilities | 3.796 B | 3.547 B | 3.973 B | 3.565 B | 3.783 B | 4.138 B | 4.475 B | 3.861 B | |
| Accounts Payable | 351.400 M | 327.900 M | 395.800 M | 413.000 M | 445.000 M | 442.300 M | 420.300 M | 461.700 M | |
| Other liabilities | 853.600 M | 876.800 M | 2.636 B | 2.559 B | 2.601 B | 2.723 B | 3.068 B | 3.116 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 361.500 M | 346.600 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 853.600 M | 876.800 M | 2.636 B | 2.559 B | 2.601 B | 2.723 B | 3.068 B | 3.116 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 18.547 B | 14.775 B | 15.631 B | 16.410 B | 16.496 B | 17.175 B | 17.319 B | 18.666 B | |
| Common stock | 258.200 M | 258.100 M | 6.908 B | 6.675 B | 6.175 B | 5.991 B | 5.014 B | 5.122 B | |
| Retained earnings | 11.242 B | 7.648 B | 8.694 B | 9.607 B | 10.253 B | 11.286 B | 12.369 B | 13.560 B |